, Singapore

New business premiums in life insurance down 2% to $1.97b in H1

The decline in single premium policies dragged half-year figures.

The life insurance industry saw new business premiums fall 2% YoY to $1.97b in in H1, according to a report by the Life Insurance Association, Singapore (LIA Singapore).

Single premium policies crashed 22% to $531.9m in H1. Single premium par and non-par products accounted for 81% of the headline figure whilst single premium linked products represented the remaining 19%. In terms of products, CPFIS-included one made up for 9% of the single premiums and cash-funded products took the remaining 91%.

In contrast, annual premium policies rose 7% YoY to $1.44b in total weighted annual premiums.

Retirement policies jumped 78% in H1 to 25,757 policies from 14,505 in H1 2018, accounting for 12% of total weighted premiums in the period. It totalled $236m in weighted premiums.

As of end-June, around 60,000 more Singaporeans and permanent residents were covered by Integrated Shield plans (IPs) and riders. It now covers 68% of Singapore’s residents.

Total new business premiums for individual health insurance for H1 amounted to $221.m, with IPs and IP rider premiums accounting for 89% or $197.3m of it. The remaining 11% or $24.1m comprised other medical plans and riders.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.